scispace - formally typeset
F

Francis G. Spinale

Researcher at University of South Carolina

Publications -  469
Citations -  24683

Francis G. Spinale is an academic researcher from University of South Carolina. The author has contributed to research in topics: Heart failure & Ventricular remodeling. The author has an hindex of 84, co-authored 451 publications receiving 23239 citations. Previous affiliations of Francis G. Spinale include Biogen Idec & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.

TL;DR: It is demonstrated that elevated steady-state MT1-MMP mRNA and protein levels occurred in DCM FIBROS despite a decline in translational deficiency, which may provide the basis for developing cell specific pharmacological targets for control of MT1,MMP expression.
Journal ArticleDOI

Common pathways and communication between the Brain and Heart: Connecting post-traumatic stress disorder and heart failure

TL;DR: Specific endocrine, autonomic, immune, structural, genetic, and physiological changes that may contribute to shared PTSD-CVD pathophysiology and could represent unique opportunities to develop therapies for both PTSD and HF are identified.
Journal ArticleDOI

Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass

TL;DR: Significant compartmentalization of endothelin exists within the human myocardium and a significantly higher and temporally disparate change in myocardial interstitial endothelins occurs during and after cardiopulmonary bypass when compared with systemic levels.
Journal ArticleDOI

Controlling myocardial matrix remodeling: implications for heart failure.

TL;DR: The development of pharmacologic agents that will modulate the activity and expression of myocardial matrix metalloproteinases represents a new and potentially significant therapeutic target for developing CHF.